ACTSI Investigator Dr. Mark Goodman in the News

Mark Goodman, PhD, ACTSI investigator and professor of radiology, psychiatry and hematology and oncology, Emory University School of Medicine

Lab Land | FDA approves Emory-developed cancer imaging probe
June 6, 2016

Emory News Center | FDA Approves Emory-Developed Prostate Cancer Imaging Probe
June 1, 2016

Yahoo News | U.S. FDA approves Blue Earth Diagnostics’ Axumin(TM) (Fluciclovine F 18) injection after priority review for PET imaging of recurrent prostate cancer
May 31, 2016

Goodman won the Start-up of 2015 Award from Emory’s Office of Technology Transfer for Microbial Medical

Lab Land | Promising probe for detecting recurrent prostate cancer
June 18, 2015

Emory News Center | Mark Goodman, PhD, earns nuclear medicine imaging award
June 1, 2012

Goodman’s project, Development and Preclinical Testing of a “L” Large Neutral Amino Acid Imaging Biomarker for Systemic Tumors with High LAT Expression was funded by the Winship Cancer Institute CCSG Fund (McCarty Fund)

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?